Publications & press
Our work, in print
What we've written about sustainability data in pharma, and what others have written about us.
As featured in
For pharma sustainability, R&D and procurement teams
On pharma, LCA data and ecodesign
Our view on footprint data in pharma: where it comes from, what makes it trustworthy, and how to use it in procurement and ecodesign.
By ElioSustainable Procurement in Drug Design: Bridging the Data Gap
Written with ten23 health: a transparent way to score lab consumables on sustainability from public product data, so procurement teams can act now instead of waiting years for supplier data.
American Pharmaceutical Review, Article, , By Elio
Read on americanpharmaceuticalreview.com(opens the publisher's site)
Mention2026 Sustainability Trend Report
CPHI's report on whether pharma can innovate and decarbonise at the same time, from Scope 3 data gaps to building sustainability in early, with input from Kami Krista. Free download after registration.
CPHI, Report, , Mention
Read on cphi-online.com(opens the publisher's site)
MentionGermanWettbewerbsvorteile durch Nachhaltigkeit
Kami Krista on why much of a drug's footprint is set in early process design, how external data can replace supplier surveys, and why sustainability now weighs in public procurement.
PHARMIG, Article, , Mention, German
Read on pharmig.at(opens the publisher's site)
MentionSustainability by Design in the Context of Bioprocess Development
Kami Krista on why sustainability belongs in early R&D and CMC decisions, before process inputs are locked into the regulatory dossier, and why process teams need fast footprint guidance.
PharmTech, Article, , Mention
Read on pharmtech.com(opens the publisher's site)
By ElioLeveraging AI & Big Data for Eco-Design Collaboration in Pharma
Co-written with ten23 health: why ecodesign in pharma depends on data shared across the value chain, and what our first design partnership on lab consumables delivered.
ONdrugDelivery, Article, , By Elio
Read on ondrugdelivery.com(opens the publisher's site)
FeatureGermanInterview mit Kami Krista, elio
Ahead of the DECHEMA FORUM 2024, Kami Krista answers three questions on more sustainable pharma processes: where AI already helps, where its potential lies, and what it can't do yet.
DECHEMA, Interview, , Feature, German
Read on dechema.de(opens the publisher's site)
Send us your list. Free and non-binding.
For investors, partners, future colleagues and the press
On Elio and the people behind it
Profiles and interviews about the company, our founders and why we're building the data layer pharma's climate goals depend on.
Closing the Climate Implementation Gap: How Elio Is Rewiring Pharma from the Inside
(opens the publisher's site)Harvard Technology Review, Article, Apr 2026Feature
Healthcare, Pharma & AI Summit 2026
(opens the publisher's site)OMMAX, Talk, Jan 2026By Elio
Kami Krista: Der Pharma-Revolutionär
(opens the publisher's site)trend., Article, May 2025FeatureGerman
Press inquiries
Writing about sustainability in pharma, product carbon footprints or ecodesign? We're glad to help with background, data questions and interviews.
About Elio
Elio provides LCA data for the chemicals no database covers. It models each chemical's production from documented synthesis routes, resolves every precursor, and calculates the footprint using industry-standard methods, with every value traceable to its source. To bring this data into the decisions that matter, Elio is also launching its Ecodesign app soon. Elio Technologies FlexCo is based in Vienna, Austria.
Spokesperson
Kami KristaCEO- Steering Committee, CPHI Sustainability Collective
- Pharma Eco-design Consortium